| Pentose and glucuronate interconversions |
2.13 |
0.00e+0 |
17/34 (50%) |
UGT2B28;DCXR;AKR1A1;...
|
| Butanoate metabolism |
2.08 |
0.00e+0 |
23/28 (82.14%) |
HMGCS2;ABAT;ECHS1;...
|
| Nitrogen metabolism |
1.99 |
6.12e-3 |
16/17 (94.12%) |
CPS1;CA2;GLUL;...
|
| Valine, leucine and isoleucine degradation |
1.98 |
4.59e-3 |
42/48 (87.5%) |
HMGCS2;DLD;ABAT;...
|
| PPAR signaling pathway |
1.96 |
3.67e-3 |
66/74 (89.19%) |
HMGCS2;SLC27A2;ACAA1;...
|
| Metabolism of xenobiotics by cytochrome P450 |
1.93 |
4.59e-3 |
49/77 (63.64%) |
UGT2B28;GSTP1;GSTM3;...
|
| Thiamine metabolism |
1.89 |
6.55e-3 |
12/15 (80%) |
AK4;AK1;ALPL;...
|
| Cholesterol metabolism |
1.85 |
8.03e-3 |
44/50 (88%) |
APOC2;SCARB1;APOH;...
|
| Mismatch repair |
1.82 |
1.12e-2 |
22/23 (95.65%) |
LIG1;RPA3;RFC2;...
|
| ECM-receptor interaction |
1.79 |
1.47e-2 |
80/88 (90.91%) |
COL1A1;TNC;COL9A3;...
|
| Peroxisome |
1.76 |
2.09e-2 |
72/82 (87.8%) |
PXMP2;SLC27A2;IDH2;...
|
| Other glycan degradation |
1.75 |
1.91e-2 |
13/18 (72.22%) |
MAN2B1;FUCA1;GLB1;...
|
| Fatty acid degradation |
1.69 |
3.74e-2 |
40/43 (93.02%) |
ECHS1;ACAA1;ALDH7A1;...
|
| beta-Alanine metabolism |
1.68 |
3.93e-2 |
25/30 (83.33%) |
ABAT;ECHS1;ALDH3A1;...
|
| Complement and coagulation cascades |
1.67 |
4.34e-2 |
76/85 (89.41%) |
CLU;CFH;F2R;...
|
| Synthesis and degradation of ketone bodies |
1.66 |
4.19e-2 |
9/10 (90%) |
HMGCS2;BDH2;HMGCS1
|
| Pentose phosphate pathway |
1.66 |
3.99e-2 |
25/30 (83.33%) |
TKT;FBP1;PGM1;...
|
| Hematopoietic cell lineage |
-1.88 |
1.64e-2 |
90/99 (90.91%) |
IL3RA;THPO;CD4;...
|
| Renal cell carcinoma |
-1.93 |
7.31e-3 |
68/69 (98.55%) |
CDKN1A;ARAF;PTPN11;...
|
| Mitophagy |
-1.93 |
1.10e-2 |
56/68 (82.35%) |
MAPK9;RHOT1;GABARAPL1;...
|
| Asthma |
-2.16 |
0.00e+0 |
25/31 (80.65%) |
IL3;HLA-DRA;TNF;...
|
